201
Participants
Start Date
December 31, 2014
Primary Completion Date
August 8, 2017
Study Completion Date
Adalimumab
Adalimumab pre-filled syringe, administered by subcutaneous injection
Lead Sponsor
AbbVie
INDUSTRY